SCYNEXIS, Inc.

?? Addressing the Rising Threat of Fungal Infections ?? In a recent interview with Infection Control Today?, our President and CEO, David Angulo, MD, shed light on a critical yet often overlooked issue in global health: the urgent need for new treatments for fungal infections. While many associate fungal infections with minor conditions, Dr. Angulo emphasizes the severe risks posed by invasive fungal diseases, which can lead to mortality rates as high as 80% among vulnerable populations, including chemotherapy patients and organ transplant recipients. SCYNEXIS is committed to positively impacting the lives of patients suffering from fungal infections by pioneering a new class of antifungal drugs - triterpenoid antifungals (the fungerps). As we continue to raise awareness and advocate for policy changes, the fight against deadly fungal infections remains a global priority. ?? Listen to the full interview with Dr. Angulo to learn more about the history and treatment of fungal diseases: https://lnkd.in/eydgPWDs #FungalInfections #GlobalHealth #SCYNEXIS #InfectionControl #AntifungalResistance

We reported our Full Year 2024 Financial Results. Learn more in our press release: https://lnkd.in/evs_zrzd

?? Celebrating International Women's Day 2025: Accelerating Action for Gender Equality ?? At SCYNEXIS, we believe that diversity and inclusion are not just ideals but essential components of our success. On this International Women's Day, we reaffirm our commitment to creating a workplace where every employee feels heard, valued, and supported, regardless of their gender identity. This year's theme, "Accelerating Action," resonates deeply with us. It challenges us to imagine a gender-equal world, one that is free of bias, stereotypes, and discrimination. A world where diversity is not only recognized but celebrated. ? We envision a workplace where differences are valued, and every voice contributes to our collective strength. Together, we can forge a path toward gender equality, ensuring that our work reflects the diverse perspectives that drive innovation and progress. ? Let’s take action today and every day to create an inclusive environment for all. Together, we can make a difference! ???? #IWD2025 #AcceleratingAction #GenderEquality #SCYNEXIS

This #ValentinesDay ??, we send appreciation to the scientists around the globe committed to providing treatments for fungal diseases. Learn how SCYNEXIS is working to help protect the world against dangerous and difficult-to-treat infectious diseases:?https://lnkd.in/edNiEVhn

We’re serving a global unmet need by developing potential treatments for life-threatening infections. Learn more about our goal to protect the world from dangerous and difficult-to-treat #FungalInfections:?https://www.scynexis.com/

Thank you to our wonderful SCYNEXIS team for your ongoing support this year. We are looking forward for what’s to come.?Wishing everyone a safe and happy 2025.?#HappyNewYear

Today we announced that we have completed the dosing of the first cohort of subjects in our Phase 1 trial of SCY-247, the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive fungal infections.??Learn more in our press release: https://lnkd.in/ekefXUXy

SCYNEXIS is committed to developing innovative treatments to fight fungal disease. Did you know Candida is one of the most common fungal causes of healthcare-associated bloodstream infections in the U.S.? Learn more about invasive candidiasis. https://lnkd.in/esi_tRXz

Happy Thanksgiving from all of us at SCYNEXIS! Here in the U.S., as we gather to celebrate, we want to express our gratitude for our incredible team, partners, and community. Thank you for being a part of our journey. Wishing you a day filled with joy, reflection, and thanks! #Thanksgiving #Gratitude #SCYNEXIS

Some species of antimicrobial resistant fungi can be naturally resistant to antifungal medication, but #AntimicrobialResistance can also develop over time as fungi are exposed to antifungal drugs. SCYNEXIS is pioneering innovative medicines to help millions of patients worldwide overcome and prevent difficult-to-treat infections that are becoming increasingly drug-resistant. #FungalDisease #USAAW https://lnkd.in/ex3tUdYn